Prostate-Specific Antigen Improves the Ability of Clinical Stage and Biopsy Gleason Sum to Predict the Pathologic Stage at Radical Prostatectomy in the New Millennium

Partin, 1997, Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathologic stage of localized prostate cancer. A multi-institutional update, JAMA, 277, 1445, 10.1001/jama.1997.03540420041027 Stephenson, 2006, Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy, J Natl Cancer Inst, 98, 715, 10.1093/jnci/djj190 Briganti, 2007, A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer, Eur Urol, 51, 112, 10.1016/j.eururo.2006.05.045 Svatek, 2006, Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer, Eur Urol, 49, 666, 10.1016/j.eururo.2005.11.032 Stephenson, 2005, Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy, J Clin Oncol, 23, 7005, 10.1200/JCO.2005.01.867 Augustin, 2004, Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathologic stage in clinically localized prostate cancer, J Urol, 171, 177, 10.1097/01.ju.0000099827.77355.a7 Conrad, 2002, Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma, J Urol, 167, 521, 10.1016/S0022-5347(01)69077-3 Graefen, 2003, Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables, Eur Urol, 43, 6, 10.1016/S0302-2838(02)00497-9 Graefen, 2002, International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy, J Clin Oncol, 20, 3206, 10.1200/JCO.2002.12.019 Shariat, 2006, Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10ng/ml, Eur Urol, 49, 293, 10.1016/j.eururo.2005.10.027 Steuber, 2006, Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy, J Urol, 175, 939, 10.1016/S0022-5347(05)00342-3 Stamey, 2004, The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?, J Urol, 172, 1297, 10.1097/01.ju.0000139993.51181.5d Kattan, 2003, Judging new markers by their ability to improve predictive accuracy, J Natl Cancer Inst, 95, 634, 10.1093/jnci/95.9.634 Gleason, 1977, Histologic grading and staining of prostatic carcinoma, 171 McNeal, 1988, Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread, Am J Surg Pathol, 12, 897, 10.1097/00000478-198812000-00001 Briganti, 2006, Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer, BJU Int, 98, 788, 10.1111/j.1464-410X.2006.06318.x Freedland, 2005, The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy, J Urol, 174, 1276, 10.1097/01.ju.0000173907.84852.ec Mitchell, 2006, Preoperative serum prostate specific antigen remains a significant prognostic variable in predicting biochemical failure after radical prostatectomy, J Urol, 175, 1663, 10.1016/S0022-5347(05)01022-0 Aus, 2005, EAU guidelines on prostate cancer, Eur Urol, 48, 546, 10.1016/j.eururo.2005.06.001 Eastham, 2003, Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations, JAMA, 289, 2695, 10.1001/jama.289.20.2695